Análisis coste-efectividad de la cirugía del glioma maligno guiada por fluorescencia con ácido 5-aminolevulínico
Authors:
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Neurología
- Vol. 30 (3) , 163-168
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- An extent of resection threshold for newly diagnosed glioblastomasJournal of Neurosurgery, 2011
- The importance of surgical resection in malignant gliomaCurrent Opinion in Neurology, 2009
- EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORMENeurosurgery, 2008
- Carmustine Implants for the Treatment of Newly Diagnosed High-Grade GliomasPharmacoEconomics, 2008
- Valor umbral del coste por año de vida ganado para recomendar la adopción de tecnologías sanitarias en España: evidencias procedentes de una revisión de la literaturaPharmacoEconomics Spanish Research Articles, 2007
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant gliomaAnnals of Oncology, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes ProjectJournal of Neurosurgery, 2003
- A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survivalJournal of Neurosurgery, 2001